Conflict$ Australia – Prof Allen CHENG

Back to Conflicts of Interest Australia COVID Policy [Part 1]

• Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health ^{(01) Allen Cheng at Alfred Health: https://www.alfredhealth.org.au/find-a-doctor/bio/dr-allen-cheng} , which has received payments from vaccine manufactureres Biocryst, George Clinical, Gilead, GSK and Merck ^{(02) ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf} , and has an appointment in the School of Public Health and Preventive Medicine at Monash University ^{(03) Allen Cheng at Alfred Health: https://www.alfredhealth.org.au/find-a-doctor/bio/dr-allen-cheng .}
• Co-Chair of ATAGI. ^{(04) ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members}
• Member of the COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Group ^{(05) ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
• Co-Chair of ATAGI’s COVID-19 Working Group ^{(06) ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members} which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
• Deputy Chief Health Officer of Victoria ^{(07) Deputy Chief Health Officer of Victoria, Allen Cheng: https://www.parliament.vic.gov.au/paec/inquiries/article/4554} and influential on coronavirus policy.
• Therapeutic Goods Administration (TGA) Advisory Committee on infectious diseases and biostatistics ^{(08) ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
• Site Investigator for a number of infectious disease studies via Alfred Health, which has received payments from vaccine manufacturers Biocryst, George Clinical, Gilead, GSK and Merck ⁽⁰⁹⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf
• Chief Investigator for influenza surveillance (FluCAN Surveillance System) ^{(10) ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
• In 2018 Chair of the Influenza Working Party which prepares advice for ATAGI ^{(11)  ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf}
• His team has recently received $1.7M from federal governments National Health & Medical Research Council (NHMRC), Refer to NHMRC section (in Part 2) for COI, towards research into how influenza virus infection results in severe illness and death in Australia ^{(12) Govt announcement $1.7M to Allen Cheng: https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/press-conference-in-melbourne-about-covid-19}

Posts tagged: ATAGI

Back to Conflicts of Interest Australia COVID Policy [Part 1]